{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:13:53Z","timestamp":1793060033899,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.semarthrit.2014.08.004","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T13:33:49Z","timestamp":1408800829000},"page":"472-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Tocilizumab for severe refractory neuro-Beh\u00e7et: Three cases IL-6 blockade in neuro-Beh\u00e7et"],"prefix":"10.1016","volume":"44","author":[{"given":"Olga","family":"Addimanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"Pipitone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Salvarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2014.08.004_bib1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00019052-200406000-00017","article-title":"Behcet\u05f3s syndrome and the nervous system","volume":"17","author":"Siva","year":"2004","journal-title":"Curr Opin Neurol"},{"issue":"6 Suppl. 36","key":"10.1016\/j.semarthrit.2014.08.004_bib2","first-page":"S46","article-title":"Clinical manifestations of Behcet\u05f3s disease in 137 Italian patients: results of a multicenter study","volume":"22","author":"Pipitone","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","article-title":"Clinical manifestations of Beh\u00e7et\u05f3s Disease: an analysis of 2147 patients","volume":"38","author":"Gurler","year":"1997","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib4","first-page":"658","article-title":"Beh\u00e7et\u05f3s Disease in Saudi Arabia","volume":"21","author":"al-Dalaan","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib5","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Behcet\u05f3s disease: evaluation of 200 patients. The Neuro-Behcet Study Group","volume":"122","author":"Akman-Demir","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.neurol.2011.09.006","article-title":"Neurological manifestations of Behcet\u05f3s disease: evaluation of 40 patients treated by cyclophosphamide","volume":"168","author":"Ait Ben Haddou","year":"2012","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/art.23345","article-title":"Infliximab for the treatment of neuro-Behcet\u05f3s disease: a case series and review of the literature","volume":"59","author":"Pipitone","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Beh\u00e7et\u05f3s disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.berh.2004.02.008","article-title":"Behcet\u05f3s disease","volume":"18","author":"Marshall","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib10","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et\u05f3s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","author":"Davatchi","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","article-title":"Effect of infliximab in progressive neuro-Beh\u00e7et\u05f3s syndrome","volume":"272","author":"Kikuchi","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clineuro.2007.10.005","article-title":"Anti-tumor necrotic factor antibody for treatment of neuro-Beh\u00e7et\u05f3s disease, a case report","volume":"110","author":"Borhani Haghighi","year":"2008","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib13","first-page":"S128","article-title":"Worsening of osteomalacia in a patient successfully treated for neuro-Beh\u00e7et\u05f3s disease with infliximab","volume":"26","author":"Madanat","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib14","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10067-011-1726-1","article-title":"Infliximab for patients with neuro-Behcet\u05f3s disease: case series and literature review","volume":"30","author":"Borhani Haghighi","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1756-185X.2009.01420.x","article-title":"Successful use of infliximab in a patient with neuro-Beh\u00e7et\u05f3s disease","volume":"12","author":"Abalos-Medina","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3109\/s10165-010-0332-4","article-title":"An attack of acute neuro-Beh\u00e7et\u05f3s disease during the course of chronic progressive neuro-Beh\u00e7et\u05f3s disease: report of two cases","volume":"20","author":"Matsui","year":"2010","journal-title":"Mod Rheumatol"},{"issue":"Suppl. 60","key":"10.1016\/j.semarthrit.2014.08.004_bib17","first-page":"S119","article-title":"Treatment of Neuro-Behcet\u05f3s disease with infliximab. An international multi-centre case-series of 18 patients","volume":"28","author":"Al-Araji","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib18","first-page":"S133","article-title":"Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Beh\u00e7et\u05f3s disease","volume":"26","author":"Belzunegui","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib19","first-page":"S102","article-title":"Switching to adalimumab is effective in a case of neuro-Behcet\u05f3s disease refractory to infliximab","volume":"28","author":"Leccese","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clineuro.2006.11.002","article-title":"A patient with neuro-Beh\u00e7et\u05f3s disease is successfully treated with etanercept: further evidence for the value of TNF alpha blockade","volume":"109","author":"Alty","year":"2007","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.clineuro.2009.02.001","article-title":"CSF levels of cytokines in neuro-Behcet\u05f3s disease","volume":"111","author":"Borhani","year":"2009","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cyto.2008.10.007","article-title":"Interleukin-6 in neuro-Behcet\u05f3s disease: association with disease subsets and long-term outcome","volume":"44","author":"Akman-Demir","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib23","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.94.4.1500","article-title":"Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain","volume":"94","author":"Heyser","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02740665","article-title":"Physiological and pathological roles of interleukin-6 in the central nervous system","volume":"15","author":"Gruol","year":"1997","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib25","doi-asserted-by":"crossref","first-page":"9041","DOI":"10.1073\/pnas.0802218105","article-title":"IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis","volume":"105","author":"Serada","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.clineuro.2011.10.024","article-title":"Tocilizumab treatment for neuro-Behcet\u05f3s disease, the first report","volume":"114","author":"Shapiro","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib27","first-page":"S73","article-title":"Refractory neuro-Behcet treated by tocilizumab: a case report","volume":"30","author":"Urbaniak","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib28","article-title":"Tocilizumab in uveitis refractory to other biologic drugs: study of 3 cases and a literature review","author":"Calvo-R\u00edo","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib29","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/rheumatology\/ket130","article-title":"Lack of efficacy of tocilizumab in mucocutaneous Beh\u00e7et\u05f3s syndrome: report of two cases","volume":"52","author":"Diamantopoulos","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2014.08.004_bib30","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00415-013-7209-3","article-title":"Diagnosis and management of neuro-Behcet\u05f3s disease: international consensus recommendations","volume":"261","author":"Kalra","year":"2013","journal-title":"J Neurol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214001863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017214001863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T10:25:39Z","timestamp":1538303139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017214001863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0049017214001863"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.08.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tocilizumab for severe refractory neuro-Beh\u00e7et: Three cases IL-6 blockade in neuro-Beh\u00e7et","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2014.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}